Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $13.44, for a total value of $403,200.00. Following the transaction, the president owned 2,042,899 shares in the company, valued at approximately $27,456,562.56. This represents a 1.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, June 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.48, for a total value of $434,400.00.
• On Wednesday, May 14th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $14.87, for a total value of $446,100.00.

Alignment Healthcare Trading Down 5.1%

NASDAQ ALHC traded down $0.67 on Friday, reaching $12.48. The company had a trading volume of 774,673 shares, compared to its average volume of 2,233,584. The firm has a market cap of $2.47 billion, a price-to-earnings ratio of -25.98 and a beta of 1.16. Alignment Healthcare, Inc. has a fifty-two week low of $7.92 and a fifty-two week high of $21.06. The business has a 50 day moving average of $14.48 and a two-hundred day moving average of $15.29. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The business had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same period in the prior year, the business posted ($0.25) earnings per share. Alignment Healthcare's quarterly revenue was up 47.5% on a year-over-year basis. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ALHC. Stifel Nicolaus upped their target price on Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Robert W. Baird boosted their price target on Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. Finally, UBS Group boosted their price target on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Alignment Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $17.17.

Institutional Trading of Alignment Healthcare

A number of large investors have recently bought and sold shares of ALHC. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after purchasing an additional 3,257,630 shares during the period. T. Rowe Price Investment Management Inc. raised its holdings in Alignment Healthcare by 54.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock valued at $97,302,000 after acquiring an additional 3,059,596 shares during the period. Millennium Management LLC raised its holdings in Alignment Healthcare by 588.3% during the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after acquiring an additional 2,896,311 shares during the period. Point72 Asset Management L.P. bought a new stake in Alignment Healthcare during the 4th quarter valued at $20,087,000. Finally, Invesco Ltd. raised its holdings in Alignment Healthcare by 1,415.7% during the 1st quarter. Invesco Ltd. now owns 1,875,790 shares of the company's stock valued at $34,927,000 after acquiring an additional 1,752,033 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.